Sunday, September 30, 2012

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news
 
Lupin aims to double sales in Japan to $500 million in next 5 years
Economic Times
The Mumbai-headquartered firm, which is present in Japan through two wholly-owned subsidiaries -- Kyowa Pharmaceutical Industry and I'rom Pharmaceuticals -- is aiming sales of $250 million (over Rs 1,300 crore) from the country this fiscal. In order to ...
See all stories on this topic »
New drug pricing policy may impact MNCs most: Analysts
Economic Times
Still a market-based policy is a balanced formula and will help improve the availability of essential medicines for patients," Organisation of Pharmaceutical Producers of India (OPPI) president and Novartis India vice-chairman and managing director ...
See all stories on this topic »

Economic Times
Dr Isa and Dr Amina Odidi 'Pharmaceutical Scientists'
AllAfrica.com
Dr Isa Odili and Dr. Amina Odidi are quite an unusual couple. Both husband and wife are top pharmaceutical scientists and prolific inventors. Currently based in Canada, these two Nigerian scientists made history when they ring the opening bell at ...
See all stories on this topic »
Critics say pharmaceutical firms spurred the increase in prescriptions for ...
Austin American-Statesman
Daniel Pilgrim, 12, looks at empty hydrocodone and oxycodone medicine bottles that belonged to his father, Lance. Lance began abusing OxyContin and spent time shuttling in and out of treatment centers after being discharged from the Army. Despite his ...
See all stories on this topic »
Russians line up to be human guinea pigs, • Pharmaceutical companies ...
Bend Bulletin
Like a dream patient conjured up in the boardroom of a pharmaceutical company, the Russian grandmother accepted the risks of the drug she was taking without complaint and cheerily endured even extraordinary side effects. As a test subject in a Russian ...
See all stories on this topic »
John Waggoner: Biotech funds prove to be good 2012 investments
Florida Today
A reason: Big pharmaceutical companies. The SPDR S&P Pharmaceuticals ETF (ticker: XPH), an index fund that follows the sector, has gained 17 percent this year. One reason for the attraction: In a time when bank CD yields are smaller than a homeopathic ...
See all stories on this topic »
A summer of research
The Sun
LOWELL -- Pharmaceuticals. "Green" polyurethane foams. Fire-resistant plastics. Those are just some of the materials that three young researchers -- Tyler Harrison of Westford, and sisters Samantha Cullum and Michaela Cullum-Doyle of Methuen -- worked ...
See all stories on this topic »
Teva acquires rights to new Huntington's disease drug
Haaretz
Teva Pharmaceutical Industries has acquired the rights to a brand drug for the treatment of the symptoms of Huntington's disease, a hereditary neurodegenerative illness. On Thursday, the Israeli company announced an asset transfer agreement with the ...
See all stories on this topic »
Home News National NA body asks for taking action against unregistered ...
Associated Press of Pakistan
Home arrow News arrow National arrow NA body asks for taking action against unregistered Pharmaceutical factories. Today is,. Sunday, 30 September 2012. Home | About Us | News | User Login | Tenders | Contact Us. Main Menu. Home · Photos at China ...
See all stories on this topic »


This once a day Google Alert is brought to you by Google.

Delete this alert.
Create another alert.
Manage your alerts.

Saturday, September 29, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
Bringing more essential drugs under control a fair policy: CII
Economic Times
While the industry welcomes this move, it would also be pertinent to note that the proposed policy will expand the span of price control to around 30 per cent of the domestic pharmaceutical market and impact revenues of the industry which is already ...
See all stories on this topic »
Shengtai Pharmaceutical, Inc. Reports Financial Results for the Fiscal Year 2012
Sacramento Bee
"We are very glad that the Company has made some important improvements in the year ended June 30, 2012," stated Qingtai Liu, CEO of Shengtai Pharmaceutical, Inc., "The Company developed a new product, corn germ meal, which can be used as animal ...
See all stories on this topic »
MNCs have 53 percent share in pharmaceutical market: National Assembly ...
Business Recorder (blog)
Multinational pharmaceutical companies have 53 percent share in Pakistan's pharmaceutical market while national companies are contended with 45 percent share, however, the estimated market growth rate is 19 percent. Joint Secretary Ministry of National ...
See all stories on this topic »
New drug pricing formula to cost Ranbaxy, GSK Dr Reddy's & others Rs 1300 crore
Economic Times
NEW DELHI: The drug pricing formula recommended by a ministerial panel will erode the revenues of pharmaceutical companies by about 1,300 crore, according to market research firm IMS Health. Among these companies, Ranbaxy, GlaxoSmithKline, ...
See all stories on this topic »
7 Pharmaceutical Stocks to Buy Now
Investorplace.com
The grades of seven Pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. Novartis (NYSE:NVS) is bettering its rating of C ("hold ...
See all stories on this topic »
Abbott Labs misstated college education of soon-to-be CEO of pharmaceutical ...
Washington Post
WASHINGTON — Abbott Laboratories said Friday it repeatedly misstated the college education of senior executive Robert Gonzalez, who is soon slated to become CEO of its $18 billion-pharmaceutical spinoff. Company regulatory filings between 2002 and ...
See all stories on this topic »
Par Pharmaceutical Announces Completion Of Acquisition By TPG
RTT News
(RTTNews) - Par Pharmaceutical Companies, Inc., (PRX:Quote) and TPG said Friday that certain affiliates of TPG have completed the acquisition of Par. As per the deal, Par's stockholders are entitled to receive $50.00 in cash for each share of Par ...
See all stories on this topic »
S&P PHARMACEUTICAL CO., LTD. : Xipei Jiang Was Invited To Participate In ...
4-traders
S&P Pharmaceutical Co., Ltd. : Xipei Jiang Was Invited To Participate In Yixing City "steady growth, promote transformation" Symposium. 09/29/2012 | 09:04am US/Eastern. Xipei Jiang Was Invited To Participate In Yixing City "steady growth, promote ...
See all stories on this topic »
Biotech and Pharmaceutical News: Walgreen (NYSE:WAG) Fights to Win Back ...
Minyanville.com
Biotech and Pharmaceutical News: Walgreen (NYSE:WAG) Fights to Win Back Express Scripts (NASDAQ:ESRX) Customers. By Alec Niedenthal Sep 28, 2012 2:10 pm. Plus, pharmas form a non-profit to expedite trials for new drugs. PRINT · Post Comments ...
See all stories on this topic »
Kufuor calls for concerted efforts to fight Neglected Tropical Diseases
Myjoyonline.com
Former President John Agyekum Kufuor, has called for partnerships among governments, pharmaceutical companies and non-governmental agencies to help eliminate Neglected Tropical Diseases (NTDs) which afflict about one billion people across the ...
See all stories on this topic »

Myjoyonline.com


This once a day Google Alert is brought to you by Google.

Delete this alert.
Create another alert.
Manage your alerts.

Friday, September 28, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
Tianyin Pharmaceutical sales decrease 26.9% to $69.6 million for fiscal year 2012
News-Medical.net
Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced ...
See all stories on this topic »
Questcor Pharmaceuticals Initiates Quarterly Cash Dividend and Expands Stock ...
Equities.com
28, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that its Board of Directors has adopted a policy to pay a regular quarterly dividend in such amounts as the Board of Directors may determine from time to time.
See all stories on this topic »
TEXT-S&P rates Watson Pharmaceuticals notes 'BBB'
Reuters
Sept 27 - Standard & Poor's Ratings Services said today that it assigned Parsippany, N.J.-based generic pharmaceutical company Watson Pharmaceuticals Inc.'s $3.9 billion senior unsecured notes offering its 'BBB' issue-level rating. The company will ...
See all stories on this topic »
Progenics Pharmaceuticals Initiates Phase 2 Clinical Trial of PSMA ADC in ...
Equities.com
28, 2012 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) has opened enrollment in a phase 2 study in prostate cancer patients of its PSMA ADC compound. PSMA ADC is a targeted anti-cancer therapeutic that uses a monoclonal ...
See all stories on this topic »
TEXT-Fitch cuts Watson Pharmaceuticals IDR to 'BBB-'
Reuters
The proposed acquisition of the Actavis Group, a privately-held global generic pharmaceutical company, for an upfront payment of EUR4.25 billion (approximately US$5.65 billion) plus additional consideration will drive up leverage to a level consistent ...
See all stories on this topic »
Sagent Pharmaceuticals Announces the Launch of Vancomycin Hydrochloride ...
MENAFN.COM
Sagent Pharmaceuticals Announces the Launch of Vancomycin Hydrochloride for Injection, USP. SCHAUMBURG, Ill., Sep 28, 2012 (Menafn - GlobeNewswire via COMTEX) --Sagent Pharmaceuticals, Inc. SGNT today announced the launch of Vancomycin ...
See all stories on this topic »
PAR PHARMACEUTICAL COMPANIES, INC. : Par Announces Completion Of ...
4-traders
28, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc., and TPG today announced the completion of Par's acquisition by certain affiliates of TPG. "This transaction has delivered significant value to our shareholders and is a strong endorsement of ...
See all stories on this topic »
GoM finalises pricing policy for 348 drugs
Economic Times
NEW DELHI: The Group of Ministers (GoM) set up to determine the country's drug pricing policy will recommend that retail prices of 348 essential drugs be fixed at the weighted average price of brands that have more than 1% market share. This will lead ...
See all stories on this topic »

Economic Times
Bayer's Stivarga® (regorafenib) Tablets Approved by U.S. FDA for Treatment of ...
Sacramento Bee
27, 2012 -- /PRNewswire/ -- Intended for U.S. Media Only -- Bayer HealthCare and Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) announced today that the U.S. Food and Drug Administration (FDA) approved Bayer's Stivarga® (regorafenib) tablets for the ...
See all stories on this topic »
Drug makers gain; not too hurt by pricing cap
Moneycontrol.com
Reuters Market Eye - Shares in pharmaceutical companies gain despite a recommendation by a ministry panel to cap drug prices given the proposal is seen as less hurtful than expected. A panel of ministers recommended capping prices for 348 drugs ...
See all stories on this topic »

Moneycontrol.com


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Thursday, September 27, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
Pharma GoM finalises pricing policy, to cover 348 'essential drugs'
Economic Times
At present, the government through the National Pharmaceutical Pricing Authority (NPPA), controls prices of 74 bulk drugs and their formulations. Fertilisers and Chemicals Minister Srikant Jena said the GoM arrived at a consensus on the option which ...
See all stories on this topic »

Economic Times
People on the move: jobs in pharma
In-PharmaTechnologist.com
in-PharmaTechnologist.com presents its weekly round-up of the lates new appointments in the pharmaceutical world, including news from Capsugel, Shire and Savient. Capsugel has appointed Donal Loughrey senior VP of operations and supply chain.
See all stories on this topic »

In-PharmaTechnologist.com
Public Citizen advocacy group tracks rise in pharmaceutical settlements with ...
Washington Post
WASHINGTON — Federal and state prosecutors have collected more than $30 billion from drug companies for alleged fraud and illegal marketing over the last 20 years, according to a new report by consumer advocacy group Public Citizen. The report shows ...
See all stories on this topic »
US FDA grants priority review status to Amitiza for opioid-induced ...
pharmabiz.com
Sucampo Pharmaceuticals, Inc. (SPI) and Takeda Pharmaceuticals USA, Inc. (TPUSA) announced that the US Food and Drug Administration (FDA) has granted priority review of their supplemental new drug application (sNDA) filing. The sNDA was filed in ...
See all stories on this topic »
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : Teva Expands Central ...
4-traders
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) announced today that it has concluded an Asset Transfer Agreement with NeuroSearch A/S of Denmark (OMX: NEUR) to purchase all rights, assets and obligations relating to Huntexil® (pridopidine / ACR16) ...
See all stories on this topic »
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) Fights for Share of Weight-loss Pill ...
HotStocked
Weight-loss therapies are the new battlefield for pharmaceutical companies in the USA, as more and more smaller drug developers are setting their research against an epidemic of obesity and general investor distrust. ARNA927.png. Arena Pharmaceuticals ...
See all stories on this topic »

HotStocked
China Nuokang to Be Taken Private for $112 Million by CEO's Wife
Wall Street Journal (India)
Nuokang Bio-Pharmaceutical, which focuses on hospital-based medical products, will be acquired by Kingbird Investment Inc., which is beneficially owned by Yuhuan Zhu, the wife of CEO Baizhong Xue. Nuokang's shares will be canceled in exchange for the ...
See all stories on this topic »
Popping pills for sleep may be bad for health
Zee News
For instance, eight out of 10 cases of insomnia were caused by underlying health problems, either physical or mental, that should be addressed, according to the Royal Pharmaceutical Society. Attempting to treat sleeplessness without tackling its root ...
See all stories on this topic »

Zee News
Brean Murray Initiates Coverage on Jazz Pharmaceuticals (JAZZ)
Daily Political
Jazz Pharmaceuticals, Inc. logo Investment analysts at Brean Murray assumed coverage on shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) in a note issued to investors on Thursday. The firm set a "buy" rating on the stock. Shares of Jazz Pharmaceuticals ...
See all stories on this topic »
GoM OK's 'control' on 348 essential drugs
Financial Express
At present, the government controls prices of 74 drugs through the National Pharmaceutical Pricing Authority (NPPA). The proposal was approved by the Group of Ministers (GoM), headed by Agriculture Minister Sharad Pawar, which finalised the overall ...
See all stories on this topic »


Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Wednesday, September 26, 2012

Google Alert - pharmaceutical news

News8 new results for pharmaceutical news
 
Shanghai Pharmaceuticals to market Aerocrine's instrument NIOX MINO and test ...
pharmabiz.com
SPH is China's third largest pharmaceutical company with more than 37,000 employees and an annual turnover exceeding 54 billion RMB (approximately 55 billion SEK or US$ 8.5 billion). The company, which is partly state owned, manufactures and markets ...
See all stories on this topic »
NovaBay Pharmaceuticals (NBY) Receives $2.6 Million From Partner Galderma
Stockhouse
26, 2012 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE:NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective market with first-in-class compounds such as its proprietary ...
See all stories on this topic »
Major Pharmaceutical Stocks Rise After Moody's Upgrades Industry to "Stable"
Stockhouse
NEW YORK, NY -- (Marketwire) -- 09/26/12 -- The Pharmaceutical Industry has faced significant headwinds in 2012 as patent cliffs and the emergence of generic drug makers have threatened billions in revenue for top selling drugs. Pharmaceutical stocks ...
See all stories on this topic »
Rexahn Pharmaceuticals Granted European Patent for Novel Anti-cancer ...
DailyFinance
ROCKVILLE, Md.--(BUSINESS WIRE)-- Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office ...
See all stories on this topic »
NPPA refuses to hike prices of imported insulins, eye drops
Business Standard
The drug price regulator National Pharmaceutical Pricing Authority (NPPA) has refused to allow multinational pharmaceutical companies to hike prices of imported insulins sold in the country. In a recent authority meeting, NPPA rejected all applications ...
See all stories on this topic »
Will Stem Cell Research Lift Pharmaceutical Stock Values?
Seeking Alpha
It was the year 1998 that human embryonic stem cells were first identified. Just nine years after that, a group of scientists in Japan were able to take skin cells and reprogram them with very powerful viruses to create an induced pluripotent stem cell ...
See all stories on this topic »
Alnylam wins infringement case vs. Canadian firm
Boston Herald
In the suit filed in January, Cambridge-based Alnylam alleged Tekmira improperly provided lipid nanoparticle-formulated small interfering RNA molecules to pharmaceutical collaborators, infringing on several patents exclusively licensed to Alnylam.
See all stories on this topic »
United States : McKesson Announces New President of US Pharmaceutical ...
Equities.com
McKesson Corporation today announced that Mark Walchirk has been named president, McKesson U.S. Pharmaceutical, effective immediately. Walchirk, who was most recently chief operating officer of McKesson Specialty Health, has held numerous ...
See all stories on this topic »


This once a day Google Alert is brought to you by Google.

Delete this alert.
Create another alert.
Manage your alerts.

Tuesday, September 25, 2012

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news
 
Mallinckrodt Announces Definitive Agreement to Acquire CNS Therapeutics, Inc.
Moneylife
Mallinckrodt, the Pharmaceuticals business of Covidien (NYSE: COV), has announced a definitive agreement to acquire CNS Therapeutics, Inc., a privately held specialty pharmaceutical company focused on developing and commercializing products for ...
See all stories on this topic »
Pharmaceuticals Wholesaling in Australia Industry Market Research Report Now ...
RedOrbit
Pharmaceuticals Wholesaling industry growth rates have slowed in line with changes to the industry's operating environment and slower growth in the Pharmaceutical Benefits Scheme. The Pharmaceuticals Wholesaling industry has also been influenced by ...
See all stories on this topic »
Bad Pharma: account of pharmaceutical industry scientific fraud is readable ...
Boing Boing
Bad Pharma: account of pharmaceutical industry scientific fraud is readable and rigorous. By Cory Doctorow at 8:06 am Tuesday, Sep 25. LATEST FEATURES. Making the Book Talismanic: An Interview with Robert Ansell. Robert Ansell is the Director of ...
See all stories on this topic »

Boing Boing
Aerocrine: Aerocrine signs distribution agreement with third largest chinese ...
The Herald | HeraldOnline.com
Aerocrine AB (STO:AERO-B) today announces the signing of an import and distribution agreement with Shanghai Pharmaceuticals Holding Co., Ltd. (SPH) for Aerocrine's products for the Chinese market. SPH is the third largest pharmaceutical company in ...
See all stories on this topic »
Cedarburg Hauser Pharmaceuticals adds capacity at Grafton plant
The Business Journal
Cedarburg Hauser Pharmaceuticals has expanded the capacity of its Grafton active pharmaceutical ingredient (API) manufacturing plant to meet increased demand. The company said it will also implement upgrades to improve safety and its systems.
See all stories on this topic »
Diebold Streamlines AmerisourceBergen® Technology Group's Service Delivery
IT News Online
25, 2012 /PRNewswire/ -- Looking to simplify its customer service operations, AmerisourceBergen® Technology Group (ABTG) has consolidated the delivery of its pharmaceutical equipment management services to Diebold, Incorporated (NYSE: DBD).
See all stories on this topic »
PropThink: China-centric SciClone is Creating Growth, Driven by Operating ...
Reuters
Three years ago SciClone, which is based in the U.S,, eliminated its in-house development program and began selling only partnered and in-licensed products as a China-focused pharmaceutical. In a PropThink exclusive interview, SciClone's CEO ...
See all stories on this topic »
Lawmakers, pharmaceutical sales companies call on administration to ...
MedReps
Lawmakers and industry officials, including medical device, biotech and pharmaceutical sales companies, are asking the Obama Administration to implement long-awaited provisions in the Sunshine Act, a bipartisan effort that will disclose payments to ...
See all stories on this topic »
Valeant Pharmaceuticals buys eye drug Visudyne from Vancouver's QLT
Montreal Gazette
Valeant Pharmaceuticals International Inc., soon to have its global headquarters in Montreal, has bought the well-known eye drug Visudyne from Vancouver's QLT Inc. for $112.5 million. The product will be added to Valeant's ophthalmology division ...
See all stories on this topic »


Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Monday, September 24, 2012

Google Alert - pharmaceutical news

News8 new results for pharmaceutical news
 
Valeant Pharmaceuticals buying Visudyne treatment for blindness from QLT
CanadianBusiness.com
Valeant, which has acquired numerous products and companies since it absorbed the former Biovail pharmaceutical business, said Monday that it sees Visudyne as a valuable addition to the company's ophthalmology business. "Not only will we be able to ...
See all stories on this topic »
Moody's upgrades pharmaceutical industry to stable
Businessweek
WASHINGTON (AP) — Moody's Investors Service upgraded its outlook for the global pharmaceutical industry on Monday, saying the multiyear wave of drug patent expirations that have squeezed profits should subside next year. The ratings service upgraded ...
See all stories on this topic »
Savient Pharmaceuticals Names John P. Hamill Chief Financial Officer
Sacramento Bee
BRIDGEWATER, N.J., Sept. 24, 2012 -- /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced the appointment of John P. Hamill as Senior Vice President & Chief Financial Officer effective today. Mr. Hamill brings over 25 years of ...
See all stories on this topic »
Ohr Pharmaceutical Initiates Phase II Trial of Squalamine Eye Drops For The ...
Sacramento Bee
NEW YORK, Sept. 24, 2012 -- /PRNewswire/ -- Ohr Pharmaceutical (OTCBB: OHRP-News) today announced the initiation of a Phase II clinical trial to evaluate the efficacy and safety of Squalamine Eye Drops for the treatment of the wet form of age-related ...
See all stories on this topic »
McKesson Announces New President of US Pharmaceutical Business
The Herald | HeraldOnline.com
SAN FRANCISCO — McKesson Corporation (NYSE: MCK) today announced that Mark Walchirk has been named president, McKesson U.S. Pharmaceutical, effective immediately. Walchirk, who was most recently chief operating officer of McKesson Specialty ...
See all stories on this topic »
Drug patents on the rise: 3488 in 5 years
Business Standard
Compare India's pharma patent number with that of Brazil, another BRIC (Brazil, Russia, India and China) nation, in a similar time band. A research paper, "Pharmaceutical Innovation, Incremental patenting and Compulsory Licensing" by Carlos M Correa, ...
See all stories on this topic »
Top pharmaceutical companies form nonprofit body to speed drug development
Business Recorder (blog)
0 Comments. E-mail · Print · PDF. Ten top pharmaceutical companies from the United States and Europe said they have formed a nonprofit organisation to accelerate the development of new drugs, a risky and expensive undertaking for companies of any size.
See all stories on this topic »
Multi-Stage Pharmaceuticals With Investment Potential In The War On Cancer
Seeking Alpha
Listed in order of their various stages of development, the choices start with a biotech without even a clinical trial running yet, then goes onto a promising biotech in a large indication phase 3 trial, and culminates with a multi-billion dollar ...
See all stories on this topic »


This once a day Google Alert is brought to you by Google.

Delete this alert.
Create another alert.
Manage your alerts.

Bullets

Total Pageviews

Pages

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Web Hosting Bluehost